DaVita is a leading US kidney care provider, specializing in dialysis services and health management for patients with chronic renal failure and end-stage renal disease. As of April 2015, the company operated nearly 2,000 kidney dialysis centers worldwide and has been listed on the Fortune 500 list numerous times. Its business expansion includes international collaborations, such as a 2011 survey of the medical services market in Jiangsu, China, conducted through the Jiangsu Provincial Overseas Chinese Affairs Office to explore potential partnerships. In May 2025, Berkshire Hathaway reduced its stake in DaVita by 200,000 shares for approximately $27.8 million.

DaVita, with kidney dialysis as its core business, utilizes advanced medical equipment and management models to provide treatment services for patients with chronic renal failure. Its services include hemodialysis, peritoneal dialysis, and patient education, and it is committed to improving the quality of care through standardized processes.
As of April 2015, the company had established nearly 2,000 dialysis centers worldwide, covering North America, Asia Pacific, and other regions. During a 2015 visit to Lu'an Shili Hospital in China, Atul Mathur, President of Asia Pacific, and David Sim, President of China, focused on inspecting the local blood purification center and exploring potential partnerships, demonstrating the implementation of DaVita's internationalization strategy.
Company Name: DaVita Corporation.
Official Domain: davita.com.
Domain Created: January 3, 1998.
Country: United States.
Headquarters: Englewood, USA.
Founded: 1994.